ランキング価格はじめての方へ
  1. 米国企業
  2. Healthcare Realty Trust Inc
  3. Raw

Healthcare Realty Trust Inc【HR】

時価総額
$60.2億
PER
外来医療用不動産の大手。外来医療施設の所有・開発・賃貸・運営を展開。2022年7月の合併でのれん約247百万ドル計上、2024年に自社株買いで30.8百万株・509.8百万ドル実施。米国主要都市（ダラス・ヒューストン・シアトル）中心に展開。
株価業績
サマリーテーブルに戻る
2011年
12月31日		2012年
12月31日		2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日		2024年
12月31日
Net income (loss)6-242546344766218315410041-282-664
Depreciation and amortization-----------453731675
Other amortization-----------254547
Share-based compensation31764677101097201432
Amortization of straight-line rent receivable (lessor)-----------233930
Straight-line Rent Liability-----------364
Gain on sales of real estate properties and other assets-----------27078110
Loss (gain) on extinguishment of debt----50-3-110-22-28--20-0
Impairment of real estate properties and credit loss reserves-----------54155314
Impairment of goodwill-------------251
Equity loss from unconsolidated joint ventures------12222-1-2-0
Distributions from unconsolidated joint ventures------1333321810
Non-cash interest from financing and real estate notes receivable-----------222
Other assets, including right-of-use-assets5316--------265635
Accounts payable and accrued liabilities295,00031512-62379-02924-195
Other liabilities------------3143
Net cash provided by operating activities112117148168191204308337340388386273500502
Acquisitions of real estate612573403072795922,3841755318526440349-
Development of real estate------2534287763384170
Additional long-lived assets-----------164231249
Funding of mortgages and notes receivable---12--------276
Investments in unconsolidated joint ventures------69----1004-
Investment in financing receivable-----------121
Proceeds from Sale, Property, Held-for-Sale-----------1,2017011,221
Contributions from redeemable non-controlling interests------------10
Proceeds from notes receivable repayments-----------2-5
Cash Acquired In Merger-----------1,160--
Net cash provided by investing activities-65,958,000-284-375-260-269-606-2,455176-667-319-4001,634349901
Proceeds from (Repayments of) Lines of Credit-----------40-385-
Borrowings on term loans-----------667--
Repayment on term loan-----------1,142-350
Repayments of notes and bonds payable-----------201925
Redemption of notes and bonds payable-----------2--
Dividends paid8593129137146159207253256276282284472458
Special dividend paid in relation to the Merger-----------1,124--
Proceeds from Issuance of Common Stock215-241152444191,74773323502512300
Common stock redemptions3818311233701253329
Common stock repurchases-------------510
Distributions to non-controlling interest holders-----------255
Redemption of non-controlling interest-----5-------1
Debt issuance and assumption costs3641203-----1311
Payments made on finance leases------------00
Net cash used in financing activities-5,628,00011322984814012,241-49923112-47-1,859-884-1,359
Increase (decrease) in cash and cash equivalents---------9681-6248-3543
Interest paid-----------113216203
Notes Assumed------------5-
Capital Expenditures Incurred but Not yet Paid5----------483140
Capitalized interest-----------134
Mortgage Loan Related to Property Sales------------5110
Non-controlling interest in sale of real estate-------------11
Contribution of real estate properties into unconsolidated joint venture-------------173
Fair Value of Assets Acquired-----------75--
Loans Assumed7----------1,759--
Senior Notes Assumed-----------2,233--